27th February 2015
Graphene could potentially be used as a strategy for tackling cancer stem cells, a new study has found.
Research from the University of Manchester found that the drug could be used to prevent or treat a broad range of cancers by using a non-toxic material.
In the Oncotarget journal, a team of researchers led by professor Michael Lisanti and Dr Aravind Vijayaraghavan showed that graphene oxide can act as an anti-cancer agent that can judiciously target cancer stem cells (CSCs).
In combination with existing treatments, graphene could lead to tumour shrinkage, prevent cancer spreading and stop it from recurring after treatment is completed.
Professor Lisanti, the Director of the Manchester Centre for Cellular Metabolism within the University's Institute of Cancer Sciences, said: “Cancer stem cells possess the ability to give rise to many different tumour cell types.”
Mr Lisanti explained that the cells are responsible for the spread of cancer within the body, which is accountable for around 90 per cent of cancer deaths.
Posted by Phillip Briggs
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.